Future Bio Secures Multi-Million Dollar Seed Funding to Advance Commercialization of Recyclable Vitrimer Bioplastics

Recently, Future Bio, an innovative company in the field of bio-renewable plastics, announced the completion of a multi-million-dollar angel round of financing. This round was led by Shanghai Glory Ventures Investment Management Co., LTD, with participation from Beijing Xianfeng Changqing Investment Consulting Ltd., XtalPi, Capital O, and Immersion Ventures. The funds will be used for team building, pilot testing, and research and development upgrades to accelerate the commercialization process of bio-renewable Vitrimer plastics. Future Bio has also established a strategic R&D partnership with XtalPi, leveraging XtalPi's AI and robotics R&D platform to achieve "atomic-level optimization" of recycled materials and processes, further improving recycling efficiency and reducing costs.

Vitrimer plastic materials were invented by French scientists as early as 2007. However, due to the complexity of their backbone molecules and other reasons, the cost of chemical synthesis is high, making large-scale application difficult. The core technology of Future Bio originates from a synthetic biology breakthrough in Jay Keasling's laboratory at the University of California, Berkeley. The team has constructed a highly integrated "cell factory" based on two model strains, *E. coli* or yeast. Using self-developed polyketide synthase, the process allows for the specific synthesis of target molecules, which are then secreted extracellularly and crystallized without the need to alter the pH of the fermentation environment or break the cell walls for extraction. This process enables the product purity to reach industrial-grade standards and reduces purification costs by 50-70% compared to traditional biomanufacturing processes.